Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for Central Neuropathic Pain in MS
NCT01604265Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in central neuropathic pain (CNP), sponsored by Jazz Pharmaceuticals plc. Started Mar 2002; status: completed.
02
Drugs
cannabidiol
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT01604265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604265.